Cytosorbents

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO

Phillip P. Chan

CEOPhillip P. Chan

Employees

149

Employees149

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1997

Founded1997

Employees

149

Employees149

CTSO Key Statistics

Market cap

73.25M

Market cap73.25M

Price-Earnings ratio

-4.10

Price-Earnings ratio-4.10

Dividend yield

—

Dividend yield—

Average volume

121.89K

Average volume121.89K

High today

$1.21

High today$1.21

Low today

$1.14

Low today$1.14

Open price

$1.20

Open price$1.20

Volume

46.85K

Volume46.85K

52 Week high

$1.61

52 Week high$1.61

52 Week low

$0.70

52 Week low$0.70

People also own

Based on the portfolios of people who own CTSO. This list is generated using Robinhood data, and it’s not a recommendation.